These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17566313)

  • 1. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
    Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
    Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
    Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
    Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.
    DeQuattro V; Lee D; Messerli F
    Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB; Curran MP; Perry CM
    Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
    Cooper-Dehoff R; Cohen JD; Bakris GL; Messerli FH; Erdine S; Hewkin AC; Kupfer S; Pepine CJ;
    Am J Cardiol; 2006 Oct; 98(7):890-4. PubMed ID: 16996868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials.
    Zou Z; Xu FY; Wang L; An MM; Zhang H; Shi XY
    J Hum Hypertens; 2011 Mar; 25(3):203-10. PubMed ID: 20535140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J; Zilles P; Compagnone D
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing microalbuminuria in type 2 diabetes.
    Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
    N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
    DeQuattro V; Lee D
    Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
    Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
    Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
    Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
    Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fixed combination of verapamil SR/trandolapril.
    Widimský J
    Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.